FASTEP
Live / Registered — Registered (as of 22 Dec 2020)
What this means for you
Registered since 22 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88866010
- Registration number
- 6230085
- Mark type
- Stylized text
- Filed
- 09 Apr 2020
- Published for opposition
- 04 Aug 2020
- Registered
- 22 Dec 2020
- Attorney of record
- Beth Felix
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, tropical diseases, and sexually transmitted diseases; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of tumors, cardiac disease, and drugs; In vitro gender prediction test kit; In-vitro ovulation prediction test kit for home use; Ovulation test kits; Pregnancy test kits for home use
Owner
- Azure Biotech, Inc., Houston, TX, US
- Azure Biotech, Inc., Houston, TX, US
- Azure Biotech, Inc., Houston, TX, US
Prosecution history
- 04 Feb 2026 — TEAS SECTION 8 & 15 RECEIVED
- 22 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Jun 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Jun 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jun 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 Jun 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 20 Nov 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Nov 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Oct 2020 — USE AMENDMENT FILED